"Specjaliści reumatolodzy, pełna diagnostyka i leczenie. Konsultacje rematologiczne, densytometria, usg stawów, kapilaroskopia"

During the past decade, Medyczne Centrum Hetmańska conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 7 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medyczne Centrum Hetmańska" #1 sponsor was "Abivax S.A." with 2 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Arana Therapeutics Ltd" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medyczne Centrum Hetmańska" #1 collaborator was "NBCD A/S" with 1 trials as a collaborator, "National Center for Research and Development, Poland" with 1 trials as a collaborator and "Nordic Bioscience Clinical Development (NBCD)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Medyczne Centrum Hetmańska" are "Rheumatoid Arthritis" (5 trials), "Arthritis, Psoriatic" (2 trials), "Diffuse Cutaneous Systemic Sclerosis" (2 trials), "Lupus Erythematosus, Systemic" (2 trials) and "Systemic Lupus Erythematosus" (2 trials). Many other conditions were trialed in "Medyczne Centrum Hetmańska" in a lesser frequency.

Most popular intervention types in "Medyczne Centrum Hetmańska" are "Drug" (15 trials), "Other" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "BMS-986165" (2 trials), "Guselkumab" (2 trials), "Methotrexate" (2 trials) and "ABX464" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medyczne Centrum Hetmańska" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Medyczne Centrum Hetmańska". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Medyczne Centrum Hetmańska, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Medyczne Centrum Hetmańska, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".